Perinatal/Neonatal Casebook
Perinatal/Neonatal Casebook
Casebook
& & & & & & & & & & & & & &
506 www.nature.com / jp
Neonatal Transport Joseph and Hageman
prognosis.1 Prior to transport to a tertiary care center, endotracheal along with L -citrulline or L -arginine to ‘‘prime’’ the urea cycle.
intubation to support or assist ventilation and prevent hypoxemia Protein should only be withheld for a short period of time. Without
may be necessary; the placement of a central line such as an protein, the body goes into negative nitrogen balance, which
umbilical arterial and/or an umbilical venous catheter may be increases the need for nitrogen excretion and worsens the
helpful in management of fluids, acidosis and supporting blood hyperammonemia.
pressure. The next goal is to remove exogenous protein. Hemodialysis
is the only means of rapidly removing ammonia from the body.6,8
Peritoneal dialysis does not remove ammonia quickly enough to MAINTENANCE THERAPY
minimize brain injury.1,7,8 While preparing for hemodialysis or There are three parts to maintenance therapy: protein-restricted diet,
extracorporeal membrane oxygenation, ammonia scavenging supplementation with citrulline or arginine, and medication which
therapy should be initiated, even prior to the diagnosis of a specific provides an alternate pathway for waste nitrogen excretion (sodium
metabolic etiology, if it is felt that alteration of the central nervous phenylbutyrate and/or sodium benzoate).1 The specifics of treatment
system status is secondary to the high ammonia level. Loading doses depend on which enzyme is deficient. A plasma glutamine level is
of L -arginine–HCl (600 mg/kg per dose), sodium benzoate (250 useful as a marker of effective therapy and should be maintained at
mg/kg per dose) and sodium phenylacetate (250 mg/kg per dose) levels <1000 M/l.4 Growth, especially length (or height), and
all in 25 to 35 mg/kg 10% dextrose solution given over 90 minutes development should be monitored closely. Poor growth is a sign of
have been recommended for emergency treatment of newborn infants inadequate dietary protein intake. Other services should also be
with hyperammonemia.1,4 Sustained infusion of these three involved: physical, occupational and speech therapy, psychology and
medications is recommended over the next 24 hours (Table 3). The genetic counseling.
doses depend on enzyme deficiency. The mechanism of action of Intermittent episodes of hyperammonemia can occur despite
these medications is as follows: benzoate binds glycine to form maintenance therapy. Potential causes include illness or drugs such
hippurate, and phenylacetate combines with glutamine, and are then as valproic acid, haloperidol and anesthetic agents. These episodes
excreted rapidly by the kidney. can also end in death or severe neurological sequelae. Once again,
Parenteral nutrition is needed to prevent protein catabolism. Use aggressive treatment is required.
glucose and intravenous fat emulsion, without protein, to maximize Whenever a patient with a urea cycle defect has symptoms of
calories. Once the ammonia level is <100 M/l and the patient is emesis, lethargy, agitation, disorientation or emotional lability, a
stable, oral or nasogastric feeds may be initiated using a protein- plasma ammonia level should be checked. If the ammonia is three
free powder. Essential amino acid supplementation may be needed, times the normal, the child should be hospitalized and treated.
Table 3 Treatment of Intercurrent Episodes of Hyperammonemia in Patients With Urea Cycle Disorders
Disorder Initial infusion Maintenance infusion
Administer over 90 min Daily dose given as
24 - hr infusion
Currently, the only way to correct the enzyme deficiency as the patient presented in this transport casebook who proved to have
permanently is liver transplant. Gene therapy is the hope of the argininosuccinic aciduria.
future. Specifically, the genes for argininosuccinic synthetase and Finally, when a term newborn infant presents with signs of mental
argininosuccinate lyase have been mapped to chromosomes 9 and 7, status changes, emesis, seizures and/or poor feeding, seriously con-
respectively.1 sider adding a plasma ammonia level to the diagnostic work-up.
SURVIVAL References
1. Burton B. Pediatric liver: helping adults by treating children. Urea cycle
Neurologic sequelae and survival depend on the length of the disorders. Clin Liver Dis 2000;4:1 – 13.
hyperammonemic coma. If the coma is less than 2 days, there is a 2. Oski F. Principles and Practices of Pediatrics, 2nd ed. Philadelphia: JB
chance for minimal sequelae, but neurologic deficits usually occur Lippincott; 1994. p. 88 – 91, 1922 – 3.
when the coma is longer than 2 days. Since the onset of ‘‘rational 3. Nelson W. Textbook of Pediatrics, 15th ed. Philadelphia: WB Saunders; 1996;
treatment,’’ the 1-year survival rate for infants ahs been 92%.1,7 p. 350 – 5.
Many who survive may have neurologic sequelae: mental retardation, 4. Burton B. Inborn errors of metabolism in infancy: a guide to diagnosis.
seizures, cortical atrophy and spastic quadriparesis. Later acute Pediatrics 1998;102:E69.
episodes from protein intake or infection can result in further 5. Barsotti R. Measurement of ammonia in the blood. J Pediatr 2001;138:S11 – 20.
morbidity and death. Few patients with urea cycle defects live into 6. Summar M. Urea cycle disorders: proceedings of a consensus conference for the
adulthood.1 management of patients with urea cycle disorders, Washington, DC, April 27 –
29, 2000. J Pediatr 2001;138:S1 – 80.
7. Msall M, Batshaw M, Suss R, Brusilow SW, Mellits ED. Neurologic outcome in
CONCLUSION children with inborn errors of urea synthesis. Outcome of urea - cycle
enzymopathies. N Engl J Med 1984;310:1500 – 5.
Early diagnosis and management are the key to minimizing 8. Summar M, Pietsch J, Deshpande J, Schulman G. Effective hemodialysis and
neurologic sequelae in infants presenting with hyperammonemia in hemofiltration driven by extracorporeal membrane oxygenator pump in
general and more specifically in infants with urea cycle defects such infants with hyperammonemia. J Pediatr 1996;128:379 – 82.